阿卡波糖与二甲双胍治疗糖尿病前期疗效的探讨

Discussion on the Efficacy of Acarbose and Metformin in the Treatment of Pre-diabetes

目的分析针对糖尿病前期患者应用阿卡波糖和二甲双胍的临床疗效。方法对照组以阿卡波糖治疗,观察组加用二甲双胍治疗。结果观察组的糖尿病发病率为12.50%,对照组为57.50%,差异有统计学意义(P<0.05);观察组空腹血糖等指标低于对照组,差异有统计学意义(P<0.05)。结论糖尿病前期患者联用阿卡波糖及二甲双胍可有效抑制糖尿病发病率。

Objective To analyze the clinical efficacy of acarbose and metformin in patients with pre-diabetes.Methods The control group was treated with acarbose,and the observation group was treated with metformin.Results The incidence of diabetes was 12.50%in the observation group and 57.50%in the control group(P<0.05).Fasting blood glucose and other indicators in the observation group were lower than those in the control group,and(P<0.05).Conclusion The combination of acarbose and metformin in patients with pre-diabetes can effectively inhibit the incidence of diabetes.